Table 2.
Discussion of adherence support tools and programs
| Automated adherence remindersa
|
Mobile administration programb
|
Symptom trackingc
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Believes adherence significantly affects outcomes?
|
Believes adherence significantly affects outcomes?
|
Believes adherence significantly affects outcomes?
|
|||||||
| Total (n=126) |
Yes (n=66) |
No (n=60) |
Total (n=126) |
Yes (n=66) |
No (n=60) |
Total (n=126) |
Yes (n=66) |
No (n=60) |
|
| Have a dedicated nurse who typically manages this, % Among those without a dedicated nurse | 24 (n=96) |
30 (n=46) |
17 (n=50) |
17 (n=104) |
20 (n=53) |
15 (n=51) |
14 (n=108) |
20 (n=53) |
8 (n=55) |
| Patients with whom physician discusses this as an option, % | 34 | 35 | 31 | 41 | 43 | 37 (P=0.024d) |
46 | 44 | 51 |
| Physicians who discuss this as an option with ≥1 patient, % | 38 | 50 | 26 (P=0.015e) |
46 | 57 | 35 (P=0.029e) |
56 | 72 | 42 (P=0.002e) |
| Total (ie, assuming having a dedicated nurse means discussing topic with 100% of patients) | |||||||||
| Patients with whom this is discussed as an option, % | 48 | 49 | 46 | 53 | 51 | 57 | 54 | 52 | 59 |
| Physicians who discuss this as an option with ≥1 patient, % | 52 | 65 | 29 (P<0.01e) |
56 | 65 | 35 (P<0.01e) |
63 | 77 | 37 (P<0.01e) |
Notes:
a
Includes e-mails, phone calls, letters, and text messages.
b
Health care providers deliver long-acting octreotide injections at home or a convenient location.
c
Diary of symptoms, test results, and side effects.
d
P-value from independent sample t-test.
e
P-value from chi-square test.